TopFunds

Cardinal Health

NYSE: CAH

Stock price

238.96 USD

(+0%) TODAY

Health Care DistributorsMedical - Distribution
Financials

all figures in US$ Millions except per share data

Sections:

Periods:

View:

Format:

Actual
10 year cagr
Help
Where available up to 10y CAGR shown for absolute numbers 10y Average marked A shown for relative numbers such as margins
Fiscal
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Average (A)
Fiscal period end dates
Expand all rows
01Earnings per share
Help
Earnings per share = Net Income / Number of Shares Outstanding
4.3
4
0.8
4.5
(12.6)
2.1
(3.3)
1.3
3.5
6.5
7.2
5.3%
02Free cash flow per share
7.6
2.5
7.6
8
5.4
6.9
9.8
9
13.2
7.6
19.1
9.7%
03Dividends per share
1.6
1.8
1.9
1.9
1.9
1.9
2
2
2
2.5
2.6
4.7%
04Dividends payout, %
35.9%
44.8%
2.3%
42.3%
(15.4)%
93.8%
(59.6)%
1.6%
58.6%
31.7%
28.7%
(2.2)%
PROFIT AND LOSS STATEMENT
05Revenue
121,546
129,976
136,809
145,534
152,922
162,467
181,326
204,979
226,827
222,578
254,248
7.7%
06% Change
-
-
-
-
-
-
-
-
-
-
-
7.7%
07Cost of revenue
(115,003)
(123,432)
(129,628)
(138,700)
(146,054)
(155,689)
(174,842)
(198,105)
(219,413)
(214,410)
(244,474)
7.8%
08Gross profit
6,543
6,544
7,181
6,834
6,868
6,778
6,484
6,889
7,414
8,168
9,774
4.1%
09% Margin
5.4%
5%
5.3%
4.7%
4.5%
4.2%
3.6%
3.4%
3.3%
3.7%
3.8%
4.3% A
10Operating expenses
(4,084)
(4,424)
(7,055)
(4,774)
(10,966)
(6,306)
(7,091)
(6,122)
(6,171)
(5,893)
(7,161)
5.8%
11% of Revenue
(3.4)%
(3.4)%
(5.2)%
(3.3)%
(7.2)%
(3.9)%
(3.9)%
(3)%
(2.7)%
(2.7)%
(2.8)%
(3.8)% A
12Operating Income
2,459
2,120
126
2,060
(4,098)
472
(607)
752
1,243
2,275
2,613
0.6%
13Income tax expense
(845)
(630)
(487)
(386)
(79)
(289)
(153)
(332)
(348)
(532)
(469)
(5.7)%
14Net Income
1,427
1,288
256
1,363
(3,693)
611
(938)
330
852
1,561
1,714
1.9%
15% Margin
1.2%
1%
0.2%
0.9%
(2.4)%
0.4%
(0.5)%
0.2%
0.4%
0.7%
0.7%
0.2% A
16Shares Outstanding
330
320
315
301
293
294
279
262
247
242
237
(3.3)%
17EPS Basic
4.4
4.1
0.8
4.5
(12.6)
2.1
(3.3)
1.3
3.5
6.5
7.3
5.3%
18EPS Diluted
4.3
4
0.8
4.5
(12.6)
2.1
(3.3)
1.3
3.5
6.5
7.2
5.3%
19EBITDA
3,095
2,842
1,133
3,045
(2,621)
1,286
55
1,439
1,962
3,106
3,478
1.2%
% Margin
2.6%
2.2%
0.8%
2.1%
(1.7)%
0.8%
-
0.7%
0.9%
1.4%
1.4%
1% A
20Net Interest Income (expense)
(178)
(201)
(329)
(294)
(238)
(180)
(147)
(84)
(51)
(215)
(348)
6.9%
21Net Debt / EBITDA
1
1.2
6.4
1.8
(1.5)
2.6
19.8
0.8
0.2
1.8
1.5
3.2 A
BALANCE SHEET
ASSETS
Current Assets
22Cash & equivalents
2,356
6,879
1,763
2,531
2,771
3,407
4,717
4,076
5,133
3,874
4,856
7.5%
23Short-term investments
-
-
-
-
-
-
-
-
-
-
-
-
24Accounts receivable
7,405
8,048
7,800
8,448
8,264
9,103
10,573
11,108
12,084
13,242
13,815
6.4%
25Other current assets
1,580
2,117
2,682
1,946
1,707
3,944
2,009
2,434
2,710
2,426
2,785
5.8%
26Inventory
10,615
11,301
12,308
12,822
13,198
14,594
15,636
16,119
14,957
16,831
17,297
5%
27Total Current Assets
21,956
28,345
24,553
25,747
25,940
31,048
32,935
33,737
34,884
36,373
38,753
5.9%
Non-Current Assets
28Net property, plant & equipment
1,796
1,879
2,487
2,356
2,366
2,360
2,361
2,461
2,529
2,858
4,022
8.4%
29Long-term investments
-
-
-
-
-
68
77
56
43
14
-
(32.6)%
30Other non-current assets
10,370
9,888
12,911
12,860
12,460
10,977
8,505
7,095
7,665
13,877
14,524
3.4%
31Total Non-Current Assets
12,166
11,767
15,398
15,216
14,826
13,405
10,943
9,612
10,237
16,749
18,546
4.3%
Total Assets
34,122
40,112
39,951
40,963
40,766
44,453
43,878
43,349
45,121
53,122
57,299
5.3%
LIABILITIES
Current Liabilities
32Accounts payable
17,306
17,906
19,677
21,535
21,374
23,700
27,128
29,934
31,759
34,713
38,283
8.3%
33Short-term debt
587
1,327
1,001
452
10
976
682
892
551
714
2,083
13.5%
34Other current liabilities
1,808
1,988
2,215
2,122
2,231
2,948
2,740
2,914
3,330
3,470
3,538
6.9%
35Total Current Liabilities
19,701
21,221
22,893
24,109
23,615
27,624
30,550
33,740
35,640
38,897
43,904
8.3%
Non-Current Liabilities
36Long-term debt
4,952
9,068
8,012
7,579
6,765
5,739
5,123
4,284
5,058
8,631
7,865
4.7%
37Other non-current liabilities
2,898
2,995
2,987
2,945
8,594
9,296
8,911
8,282
7,635
8,228
8,254
11%
38Total Non-Current Liabilities
7,850
12,063
10,999
10,524
15,359
15,035
14,034
12,566
12,693
16,859
16,119
7.5%
39Total Liabilities
27,551
33,284
33,892
34,633
38,974
42,659
44,584
46,306
48,333
55,756
60,023
8.1%
SHAREHOLDERS` EQUITY
40Common stock
3,010
2,697
2,730
2,763
2,789
2,806
2,813
2,746
2,917
2,956
2,887
(0.4)%
41Retained earnings / (deficit)
6,419
4,967
4,645
5,434
1,170
1,205
(280)
(642)
(286)
783
2,009
(11)%
42Accumulated other comprehensive income / (loss)
(116)
(125)
(92)
(79)
(104)
(34)
(114)
(151)
(167)
(155)
(165)
3.6%
43Noncontrolling interests
17
20
-
2
3
3
3
1
1
147
159
25.1%
44Total shareholders' equity
6,571
6,828
6,059
6,330
1,792
1,794
(706)
(2,957)
(3,212)
(2,634)
(2,724)
-
45Total Liabilities and shareholders' Equity
34,122
40,112
39,951
40,963
40,766
44,453
43,878
43,349
45,121
53,122
57,299
5.3%
46Total Debt
5,539
10,395
9,013
8,031
6,775
6,715
5,805
5,176
5,609
9,345
9,948
6%
47Net Debt
3,183
3,516
7,250
5,500
4,004
3,308
1,088
1,100
476
5,471
5,092
4.8%
CASH FLOW STATEMENT
CASH FLOWS FROM OPERATING ACTIVITIES
48Net income (loss)
1,427
1,288
256
1,363
(3,693)
611
(938)
330
852
1,561
1,714
1.9%
49Depreciation & amortization
641
717
1,032
1,000
913
783
723
692
710
790
956
4.1%
50Share-based compensation expense
111
96
85
82
90
89
-
96
121
244
367
12.7%
51Changes in working capital and other assets
792
(917)
1,395
277
4,650
946
3,337
1,726
2,079
(198)
2,137
10.4%
52Net cash flows from operating activities
2,971
1,184
2,768
2,722
1,960
2,429
3,122
2,844
3,762
2,397
5,174
5.7%
CASH FLOWS FROM INVESTING ACTIVITIES
53Purchases of property, plant and equipment
(465)
(387)
(384)
(328)
(375)
(400)
(387)
(481)
(511)
(547)
(649)
3.4%
54Purchases of investments / marketable securities
(200)
(194)
(9)
(18)
(20)
(22)
(78)
-
(550)
-
-
13.5%
55Proceeds from maturities of marketable securities
186
305
65
3
886
47
100
29
384
202
41
(14)%
56Other investing activities
(3,601)
(129)
(5,280)
681
2
(3)
932
(2)
(1,172)
(5,260)
(1,976)
(5.8)%
57Net cash flows from investing activities
(4,080)
(405)
(5,608)
338
493
(378)
567
(454)
(1,849)
(5,605)
(2,584)
(4.5)%
CASH FLOWS FROM FINANCING ACTIVITIES
58Issuance (repurchases) of common stock, net
(651)
(600)
(550)
(600)
(350)
(200)
(1,000)
(2,000)
(750)
(765)
(1,358)
7.6%
59Dividends paid, net
(512)
(577)
(581)
(577)
(569)
(573)
(559)
(525)
(499)
(494)
(491)
(0.4)%
60Debt issuance (repayments), net
20
4,864
(1,001)
(1,102)
(1,401)
(570)
(885)
(579)
356
3,224
337
32.6%
61Other financing activities
4
59
(144)
(14)
120
26
(19)
53
46
(13)
(90)
-
62Net cash flows from financing activities
(1,139)
3,746
(2,276)
(2,293)
(2,200)
(1,317)
(2,463)
(3,051)
(847)
1,952
(1,602)
3.5%
63Increase (decrease) in cash and cash equivalents
(2,260)
4,523
(5,116)
768
240
636
1,310
(669)
1,057
(1,259)
982
-
64Cash and equivalents, ending balance
2,356
6,879
1,763
2,531
2,771
3,407
4,717
4,076
5,133
3,874
4,856
7.5%
65Free Cash Flow to the Firm (FCFF)
Help
Free Cash Flow to the Firm = Cash Flows from Operating Activities - Capital Expenditures
2,506
797
2,384
2,394
1,585
2,029
2,735
2,363
3,251
1,850
4,525
6.1%

Annual Reports, Presentations And IR Contacts

Go to the website
Annual report links (10K)
20262025202420232022202120202019201820172016

Cardinal Health (CAH) financial statements and performance

Explore Cardinal Health (CAH) annual and quarterly financial statements, including revenue, operating income, net income, cash flow, assets, liabilities, and per-share metrics.

Compare reporting periods and financial trends to evaluate profitability, balance-sheet strength, cash generation, and long-term business performance.